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Background: Drug overdoses (fatal and non-fatal) are among the leading causes of death
in population with substance use disorders. The aim of the current study was to identify risk
factors for fatal and non-fatal drug overdose for predominantly opioid-dependent
treatment–seeking population.
Methods: Data were collected from 640 adult patients using a self-reported 25-item
Overdose Risk (OdRi) questionnaire pertaining to drug use and identified related domains.
The exploratory factor analysis (EFA) was primarily used to improve the interpretability of
this questionnaire. Two sets of EFA were conducted; in the first set of analysis, all items
were included, while in the second set, items related to the experience of overdose were
removed. Logistic regression was used for the assessment of latent factors’ association
with both fatal and non-fatal overdoses.
Results: EFA suggested a three-factor solution accounting for 75 and 97%of the variance for
items treated in the first and second sets of analysis, respectively. Factor 1 was common for
both sets of EFA analysis, containing six items (Cronbach’s α  0.70) focusing around “illicit
drug use and lack of treatment.” In the first set of analysis, Factors 2 (Cronbach’s α  0.60) and
3 (Cronbach’s α  0.34) were focusing around “mental health and emotional trauma” and
“chronic drug use and frequent overdose” domains, respectively. The increase of Factor 2 was
found to be a risk factor for fatal drug overdose (adjusted coefficient  1.94, p  0.038). In the
second set of analysis, Factors 2 (Cronbach’s α  0.65) and 3 (Cronbach’s α  0.59) as well as
Factor 1 were found to be risk factors for non-fatal drug overdose ever occurring. Only Factors
1 and 3 were positively associated with non-fatal overdose (one in a past year).
Conclusion: The OdRi tool developed here could be helpful for clinical studies for the
overdose risk assessment. However, integrating validated tools for mental health can
probably help refining the accuracy of latent variables and the questionnaire’s consistency.
Mental health and life stress appear as important predictors of both fatal and non-fatal
overdoses.
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INTRODUCTION
The rates of drug-related deaths (DRDs) and non-fatal drug-
related overdoses (ODs) of opioid users are increasing (Iversen
et al., 2016). Illicit and licit drug overdose is a leading cause of
premature death and morbidity among this population (Darke
et al., 2003; Iversen et al., 2016). Worldwide, overdose-related
mortality accounts for 0.65 (0.55–0.75) per 100 person-years,
followed by trauma and suicide-related deaths, with values of 0.25
and 0.12, respectively (Degenhardt et al., 2011). In Scotland, 49%
of the drug treatment seeking population had experienced a drug
overdose at some time in the past and 11% had overdosed in the
past 3 months (Bohnert et al., 2011).
A review of the risks of fatal drug overdose in opioid users
identified the following three key components (Frisher et al.,
2012): 1) individual—relating to the drug (licit or illicit) users; 2)
situational—circumstances surrounding an overdose; and 3)
organizational—the response to an overdose incidence.
Taken together, these components lead to a complex set of risk
factors which will influence the likelihood of a drug overdose
occurrence being fatal (European Monitoring Centre for Drugs
and Drug Addiction, 2015). Given the premise that multiple
variables will influence the risk of drug overdose, it is important to
develop preventative measures which can take account of
multiple components and provide a more tailored approach to
opiate overdose. To date, research has focused on identifying
individual person-centered characteristics and circumstances as
risk factors. The severity of dependence, recent prison release,
recent detoxification, polysubstance use, social deprivation,
history of suicide attempt, recent hospital discharge, length of
drug using career, number of network members who inject drugs,
lifetime history of negative life events, male gender, and
homelessness have all been reported as risk factors for fatal
opioid-related overdoses (Wolff, 2002; Neale and Robertson,
2005; Coffin et al., 2007; Rome et al., 2008; Backmund et al.,
2009; Bohnert et al., 2010; Merrall et al., 2010; Jenkins et al., 2011;
Frisher et al., 2012; Mathers et al., 2013).
However, the relative impact of these factors on overdose risks,
or how the factors may combine to predict the risk of
experiencing a fatal drug overdose, remains poorly
determined. Despite the considerable scope of the problem,
the independent predictive factors for opioid-related drug
overdoses have not been the subject of robust methodological
evaluation (Laupacis et al., 1997; McGinn et al., 2000; Reilly and
Evans, 2006). This problem is likely to get worse given the aging
population of opioid drug users in the United Kingdom (Public
Health England, 2016). A recent survey of 123 drug users over
35 years found 75% had overdosed at some point in their lives
and 33% in the last 12 months. Extrapolation to the drug using
population in Scotland estimated that 4,500 drug users aged over
35 years will experience an overdose event annually (Matheson
et al., 2019). As this group has multiple health challenges and
problems of social isolation, the number of fatal overdoses should
be expected to increase.
Perception of risk is conceptualized in terms of 1) personal
vulnerability to the health effects of their risky behavior through
knowledge acquisition (Kotchick et al., 2001), 2) “optimistic bias”
(inaccurate estimation of lower personal risk in comparison to
other counterparts), and 3) “precaution effectiveness” (believing
that engaging in precautionary behavior will be beneficial to their
health) (Peretti-Watel, 2003). As a result, this cognitive process
could increase vulnerability to drug overdose.
For overdose prevention and response research, a broad
assessment capable of capturing behavioral risks in
populations with varying substance choices and use patterns is
critically important, particularly as we seek to understand the
precipitants of changes in overdose risk behaviors among at-risk
populations. To better understand the factors that cause opioid-
related overdose, a first step is to comprehensively assess overdose
risk behaviors and test their associations with overdose events.
One difficulty in preventing fatal as well as non-fatal drug
overdoses is that the risk factors for such episodes are not well
understood, and therefore, at-risk individuals cannot be reliably
identified and interventions cannot be targeted at those most at
risk. To date, research has focused on identifying isolated
characteristics and circumstances as risk factors, such as age,
gender, previous overdoses, being homeless, recent prison release,
and adverse life events (Rome et al., 2008). However, as there is no
understanding about the relative impact of these factors on drug
overdose risks, or how these factors may combine to affect the risk
of suffering an overdose, the ability to predict overdoses and
fatality remains poor (see (Fischer et al., 2015) for an overview).
To date, longitudinal work with substance abusers has been
focused on understanding the risk factors for moving from
substance use to dependence (Wittchen et al., 2008; Swendsen
et al., 2009). Such work has highlighted the importance of
sociodemographic and gender factors when estimating risk in
this population. However, despite the considerable scope of the
problem, the risk factors relating to drug overdoses have never
been examined in a comprehensive, principled, and
methodologically rigorous manner.
The present study proposes to address this issue by piloting a
data collection form (overdose risk assessment (OdRi)
questionnaire) designed to link drug overdose risk factors in a
cohort of treatment-seeking opioid-dependent population in
Scotland to actual incidences of fatal and non-fatal drug
overdoses these individuals subsequently experience
(Supplementary Material). As such, this study would help
start identifying the quantitative weighting of risk factors for
fatal and non-fatal drug overdoses, both in isolation and in
combination. Such understanding would be fundamental to
targeting specific interventions more effectively to those most
at risk for suffering overdoses, with the potential to prevent such
outcomes and ultimately save lives. This will also help establish
algorithms to support ecologically valid user applications that can
predict outcomes to risky behaviors in this population.
DESIGN AND METHODS
Information and Ethical Governance
Approvals
The OdRI study received the Caldicott Guardian approval from
NHS Fife in November 2010. Following consultation with the
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local ethics committee and the joint Medical Research Council
and National Health Service (NHS) Health Research Authority
decision-making tool, the OdRi study team were notified that this
study does not need ethical approval.
Participants and Sample Size
The participants for this study are patients of the National Health
Service (NHS) Fife Addiction Services, which treats
approximately 1900 substance users at any one time.
In Fife, on average, there have been 30 fatal drug overdoses
(drug deaths) each year over the past 6 years. Of these, around
50% were known to NHS Fife Addiction Services (Baldacchino
et al., 2009; Baldacchino et al., 2010; Frisher et al., 2012; Bartoli
et al., 2014). Therefore, during a data collection period of
12 months, it was anticipated that approximately 10
individuals (of the 600) would suffer a fatal drug overdose.
The anticipated numbers of non-fatal overdoses are somewhat
more difficult to estimate. The Scottish Ambulance Service attend
around 15 non-fatal overdoses (illicit and licit) each week in Fife
with a guesstimate that only about 30% of these are individuals
known to Fife NHS Addiction Services. Therefore, over a 12-
month period, it was estimated that around 84 non-fatal drug
overdose events were likely to occur in individuals known to Fife
NHS Addiction Services (note that these are overdose incidents,
not number of individuals—i.e., a single individual is likely to
suffer repeated overdoses). One longitudinal study of a cohort of
Scottish drug users receiving treatment for substance use disorder
has found that 49% of the sample had overdosed at least once in
the past, and 11% had done so in the past 3 months (McKeganey,
2008).
For the purpose of this pilot study, 640 individuals that were
referred to NHS Fife Addictions Services for opioid dependence
completed an OdRi questionnaire during their initial assessment
between 2010 and 2012. These OdRi data were then followed up
during the subsequent 5-year period for incidents of fatal and
non-fatal drug overdoses and additional proxy measures of
morbidity and mortality as indicated through the linkage of
clinical datasets of the cohort studied.
Overdose Risk Assessment Questionnaire
Overdose risk factors initially identified through a systematic
review as “individual,” “situational,” and/or “organizational” risk
factors were subcategorized into the following:
1) Personal and situational
• Emotional trauma: items 18–20;
• Physical health: items 9 and 21;
• Mental health: items 6, 7, 15, and 22;
• Extrinsic stress and heavy intoxication: items 5, 14, and 17;
• Experience of overdose recently: items 9–11;
2) Organizational;
• Lack of treatment: items 1, 2, 4, 12, 13, 16, and 24;
• Medication-assisted treatment (MAT): items 3 and 25;
• Homeless: items 8 and 23;
Additionally, as part of preparing an EMCDDA report
(Robertson, 2010) on identifying and quantifying overdose risk
factors, a Delphi study was also undertaken in order to cross
validate the above categories from the systematic review. Based on
this methodology, an overdose risk assessment (OdRi)
questionnaire was designed (Humphris et al., 2013; Fischer
et al., 2015).
This OdRi questionnaire is a 25-item self-reported measure
assessing risk of fatal and non-fatal overdoses. Each item is rated
from 0 (No) to 1 (Yes), and a higher score indicates a higher risk
of overdose (Supplementary Material: OdRi questionnaire).
Data Linkage
All treatment-seeking opioid-dependent users attending NHS
Fife Addiction Services completed this overdose risk
assessment (OdRi) questionnaire with a clinical staff member.
These data were inputted into an NHS electronic system and then
deposited, in an anonymized and coded electronic format, into
the Health Informatic Centre (HIC) Safe Haven (University of
Dundee, Health Informatic Centre (HIC), 2015) for it to be
subsequently interrogated by the researchers of this pilot study
within a time-limited period. HIC Services is a University of
Dundee research support unit within the Farr Institute-Dundee,
in collaboration with NHS Tayside and NHS Fife.
This database was expanded through linkage processes to
include overdose events which these individuals experience
over the following 5-year period. Information about overdoses
was obtained from the A&E and hospital discharge records (for
non-fatal overdoses) and procurator fiscal (for fatal overdoses).
Other datasets used within the Health Informatic Centre (HIC)
safe haven include 1) Scottish Morbidity Register (SMR) 01 and
SMR04 datasets which register all hospital medical and
psychiatric admissions, respectively, and 2) SMR25a/b which
records new treatment episodes for substance misuse.
Demographic data were also collected, including the Scottish
Index of Multiple Deprivation (SIMD) (1 most deprived and
10 most affluent). The CHI (Community Health Index)
number, a unique patient identifier, was used to link
healthcare records to the abovementioned datasets held within
the HIC.
All relevant data were anonymized for the researcher when
conducting the analysis.
Statistical Analysis
Stata 14 (Stata Corporation, College Station, TX, United States,
2015) was used for data management and statistics. The data
analyzed were based on a factor analysis followed by logistic
regression in order to gain initial insights into the relative
strength of the individual risk factors in predicting fatal and
non-fatal drug overdoses.
Before operating the explanatory factor analysis, the
Kaiser–Meyer–Olkin (KMO) test and the Bartlett’s test of
sphericity were used to evaluate the factorability. We opted for
the exploratory factor analysis with oblique rotated (Promax)
tetrachoric correlation matrix in order to collapse the
questionnaire items into interpretable underlying factors. This
approach was retained because of the binary format of the OdRi
questionnaire items (Muthén, 1978; Muthén and Hofacker, 1988;
University of Dundee, Health Informatic Centre (HIC), 2015).
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Only items with a communality above 0.4 (Osborne et al., 2008)
and loading factor >0.4 were retained in the Results section. The
three factors retained were as follows:
1. Illicit drug (usually heroin and benzodiazepine) and alcohol
use and lack of treatment
2. Mental health and emotional trauma
3. Chronic drug use and frequent overdose
Factor retention was based on their interpretability along with
the scree plot examination (Cattel, 1966) and Kaiser criteria of
Eigenvalue >1 (Kaiser, 1960). The reliability of items was
examined by computing the Cronbach’s alpha coefficient
(Santos, 1999).
For fatal drug overdose, all 25 items were included in the
exploratory factor analysis, while for non-fatal drug overdose
events, the same explanatory factor analysis was repeated with the
exclusion of items 9 to 11. Logistic regression was used to assess
factors predicting fatal and non-fatal overdoses. In adjusted
analysis models, age and sex were introduced as covariates.
Risk was expressed as odds ratio (OR) with 95% confidence
interval [95% CI]. Alpha risk was set at 5%.
RESULTS
Demographics
Completed data from 640 participants were used for the current
analysis. The average age of participants was 42.2 ± 0.3 years, and
30.2% of them were women. The mean Scottish index of multiple
deprivation (SIMD) was 2.9. Of the participants, 8.6% (n  55)
died due to an fatal drug overdose (drug death), 38.2%
experienced at least one non-fatal drug overdose across their
life span, and 6.9% experienced a non-fatal drug overdose during
the last year, while 2.2% experienced two or more non-fatal drug
overdoses during the last year. All steps that were undertaken to
develop and validate the questionnaire were reported as a
Supplementary Material (Supplementary Figure S1).
Fatal Drug Overdose
EFA suggested a three-factor solution accounting together for
75% of the total variance.
Internal reliability: Overall, the questionnaire showed a
questionable reliability level of 0.645. Subgroup analysis of
Factors 1–3 (Table 1) showed a satisfactory level for the item
belonging to the first factor (illicit drug use), while reliability was
questionable too low for the second (mental health and emotional
trauma) and the third (chronic drug use and overdose) factors.
Predictability of fatal drug overdose: Results displayed in
Table 2 showed that the increase of the Factor 2 (Mental
health and emotional trauma) score by one unit increases the
risk of fatal drug overdose by nearly two-fold.
Non-Fatal Drug Overdose
EFA suggested a three-factor solution accounting together for
97% of the total variance.
Internal reliability: The first factor showed an acceptable
reliability (α  0.70), while the second (α  0.65) and third
(α  0.59) factors showed questionable and poor reliability,
respectively (Table 3).
Predictability of non-fatal drug overdose: According toTable 2,
the regression analysis showed that all the three factors are






















1 Current heroin user (smoke and snort) 0.71 0.70
2 Current intravenous drug use 0.71
3 Current prescription for opiate dependence (methadone, buprenorphine, and
suboxone)
−0.69
13 Having to use increasing amounts of drugs to become intoxicated 0.59
16 Tends to use alone 0.83
25 At the beginning of treatment 0.64
7 Poly use of CNS depressants (include prescription psychotropic medication, that is,
antidepressants and antipsychotics)
0.63 0.60
18 Domestic abuse past or present 0.73
19 Domestic abuse past or present 0.75
20 Past termination or miscarriage (women only) 0.56
22 Mental health diagnosis 0.62
10 Has been in prison, hospital, or residential detox in preceding month, or currently on
detox prescription
0.63 0.34
11 Has overdosed accidentally/intentionally two or more times in the past year 0.72
12 Has been using drugs for more than 5 years −0.69
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significantly associated with non-fatal drug overdose (ever), while
only the first and the third factors are significantly associated with
experiencing a drug overdose during the past year. The increase
of the Factor 1 (illicit drug use) score by one unit increases the risk
of more than one overdose during the past year by three-fold.
DISCUSSION
Summary and Questionnaire Validity
In this study, data from 640 patients were collected from the
National Health Service (NHS) Fife Addiction Services using the
OdRi questionnaire. This pilot study aimed to start identifying
the quantitative weighting of risk factors for fatal and non-fatal
drug overdoses.
The exploratory factor analysis, tetrachoric correlation matrix,
for fatal overdose identified three factors, namely, Factor 1 “illicit
drug use and lack of treatment,” Factor 2 “mental health and
emotional trauma,” and Factor 3 “chronic drug use and frequent
overdose.” A similar number of factors were identified for non-
fatal overdose, but the mental health item was loaded on a third
factor along with drug use–related items. The overall
questionnaire’s (all items) internal consistency was
questionable; however, after running factor analysis, we found
that items of the Factor 1 (in both fatal and non-fatal overdose
data analysis) items reached an acceptable value. Items of Factors
TABLE 2 | Logistic regression for the association between latent factors with fatal and non-fatal drug overdoses.
Crude analysis Adjusted analysis
OR 95% CI OR 95% CI
Fatal drug overdose
Factor 1(illicit drug use and lack of treatment) 0.71 0.29–1.74 0.70 0.28–1.72
Factor 2 (mental health and emotional trauma) 1.76 0.98–3.17 1.94 1.03–3.63
Factor 3 (chronic drug use and frequent overdose) 0.61 0.21–1.77 0.61 0.21–1.79
Non-fatal drug overdose (ever)
Factor 1 (illicit drug use and lack of treatment) 1.85 1.13–3.04 1.80 1.09–2.97
Factor 2 (emotional trauma) 1.99 1.23–3.20 2.74 1.51–4.95
Factor 3 (chronic drug use and mental health) 3.18 1.97–5.15 3.39 2.07–5.57
Non-fatal drug overdose (one in a past year)
Factor 1 (illicit drug use and lack of treatment) 3.73 1.60–8.69 3.82 1.61–9.06
Factor 2 (emotional trauma) 2.09 0.91–4.81 2.23 0.78–6.34
Factor 3 (chronic drug use and mental health) 3.53 1.58–7.87 3.13 1.36–7.19
Non-fatal drug overdose (one or more in a past year)
Factor 1 (illicit drug use and lack of treatment) 8.69 2.12–35.5 7.54 1.81–31.4
Factor 2 (emotional trauma) 2.89 0.73–11.4 2.74 0.48–15.72
Factor 3 (chronic drug use and mental health) 0.64 0.11–3.64 0.56 0.09–3.45
TABLE 3 | Exploratory factor analysis and internal consistency for non-fatal drug overdose episodes.
Non-fatal drug overdose
Factor 1










1 Current heroin user (smoke and snort) 0.69 0.70
2 Current intravenous drug use 0.73




13 Having to use increasing amounts of drugs to become intoxicated 0.61
16 Tends to use alone 0.70
25 At the beginning of treatment (titration prescription) 0.68
18 Domestic abuse past or present 0.82 0.65
19 Emotional/sexual abuse past or present 0.70
20 Past termination or miscarriage (women only) 0.78
7 Poly use of CNS depressants (include prescription psychotropic
medication, i.e., antidepressants and antipsychotics)
0.78 0.59
22 Mental health diagnosis 0.74
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2 and 3 fell below the requirement for internal consistency, which
could be attributed to the low number of items or due to the poor
interrelatedness between items (Tavakol and Dennick, 2011). It is
unexpected that the obtained internal consistency of both Factors
2 and 3 could be attributed to constructs’ heterogeneity. Indeed, a
difference in participants’ characteristics may evolve a large
interindividual variability and then impact the homogeneity of
measurement items (Tavakol and Dennick, 2011). However, in
our study, we have very few measurements of individual
characteristics. For example, the subjects’ education level was
not measured. Of note, the questionnaire’s multidimensionality
might contribute to the poor internal consistency of certain items
(Tavakol and Dennick, 2011). Beyond that, the internal
consistency is proportional to the number of items, and the
low item number might alter the questionnaire performances.
Bernardes Santos et al. (Santos et al., 2009) indicated that the
combination of scales assessing independent constructs might
introduce bias in internal consistency interpretation.
Interpretation
This study showed that mental health factors were positive predictors
of both fatal and non-fatal overdoses. In the available literature,
individuals suffering from mental health have been reported to be
more likely to experience drug abuse and then to have an increased
risk of opioid overdose (Cicero and Ellis, 2017). Specifically,
depression was associated with fatal (Foley and Schwab-Reese,
2019) and non-fatal (Tobin and Latkin, 2003) overdoses.
Noticeably, our results were in agreement with a growing body of
literature showing that early life stress is associated with both forms of
overdoses (Braitstein et al., 2003; Cutajar et al., 2010; Khoury et al.,
2010; Lake et al., 2015). For example, participants from two Canadian
cohort studies (n  1,679) found that physical, sexual, and emotional
abuse during childhood increased (1.5-fold) the risk of non-fatal
overdose (Lake et al., 2015). These findings highlight the need for
systematically screening for mental health and emotional trauma in
order to predict fatal and non-fatal overdoses. While limited
importance has been given to the mental health component in
drug overdose developed questionnaires at the time of study,
Fendrich et al. (2019) suggested integration of validated
questionnaires for mental health rather than introducing few self-
reported items as in the study by Butler et al. (2008). Indeed, Fendrich
et al. (2019) have combined four validated scales, for depression
(PHQ-9 questionnaire), severe anxiety (Beck Anxiety Inventory),
post-traumatic stress disorder (Mini-International Neuropsychiatric
Interview), and psychosis (Behavior and Symptom Identification
Scale-24). They found that individuals with severe depression,
post-traumatic stress disorder, or psychosis have an increased risk
(2.5-fold) to experience a drug overdose during the previous 3months.
In comparison to Factor 2, Factor 1, that is, “Illicit drug use and
lack of treatment,”was found to be a predictor of recent and lifetime
non-fatal drug overdose. Individuals who are not and/or have just
been stabilized in a treatment program continue to experience drug
overdose. Additionally, individuals who are integrated within a drug
treatment program are also at risk of further non-fatal overdose due
to increasing susceptibility for overdose through reduction of individual
tolerance (Pollini et al., 2006). Moreover, multi-substance use may
complicate treatment and management of addiction.
Finally, it is worth to mention that there was not a significant
association between age and gender with fatal and non-fatal
overdoses.
Strengths and Limitations
The study accounts on the OdRi questionnaire that drives from an
exhaustive literature review for risk factors of overdose. Indeed, the
questionnaire gathers several factors related to overdose, including
“individual,” “situational,” and/or “organizational” ones. Second, the
important number of patients enrolled in this study would increase
the generalizability of the results obtained from this study. Finally,
stringent criteria were used for the exploratory factor analysis and
factor identification.
Our study has some limitations. The patients were not randomly
selected, so no inference could be made to general population of illicit
drug and substance users in Scotland. Second, the self-reported data
may introduce a recall bias. Third, no validated scales were used for
the assessment of specific aspects ofmental health (i.e., depression and
anxiety). Fourth, emotional trauma (including all forms) might be
underreported. Fifth, our study includes few potential confounders
(i.e., age and sex); then an extension to others such as socioeconomic
level and family context should be warranted. The analyses were
conducted among patients from low-income areas as mirrored by the
mean Scottish index of the multiple deprivation index. Then, the
strengths of association between the constructs and overdose
occurrence (both fatal and non-fatal) might be different in high-
income areas. Finally, the response collected about health problems
was subjective as no clinical diagnosis was realized. The establishment
of these data for this study could have been enhanced by using tertiary
data such as clinical notes and electronic portal systems.
Clinical and Public Health Relevance
The ultimate importance of this work lies in the potential to greatly
enhance our current knowledge of the risk factors underlying drug
overdoses. This is of utmost importance knowing that in Scotland,
1,339 drug-related death cases were identified in 2020 (National
records of Scotl, 2021), and nowadays, it is estimated to be the
highest rate in Europe. Such information would help identify
individuals most at risk, facilitating more targeted and timely
interventions, and thereby save lives. The understanding of the
relative importance of the risk factors for suffering fatal and non-
fatal drug overdoses that would be gained by the present study is also
fundamental to the development of an overdose risk assessment tool.
This is one of the future directions of this line of research, should the
study be successful in securing funding in the future. The data
collection process would be continued in Fife in order to expand the
sample size to obtain more reliable results. If successful, this process
could be set up in other services and regions, expanding the sample
size and potential knowledge gain even further. Knowledge transfer
and exchange to policy-makers, professionals, substance misuse
treatment service users, the general public, families, and careers
are an essential outcome of the proposed study, and the study team
are very well placed to disseminate the study findings in their
respective roles.
It will also be a unique opportunity to established highly
predicable algorithms which can be used to establish user
applications that can be therapeutic in nature and empowering
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for the service user. It will help build on the work initiated by the
EU-funded ORION project (http://orion-euproject.com/) which
established a PC-based eHealth tool. This can be further
developed using a mobile digital application platform.
CONCLUSION
Our study represents the first application of theOdRi questionnaire for
the assessment of the overdose risk factors. Further studies are needed
to assess the questionnaire’s reproducibility (test–retest approach) for
internal consistency. However, our study showed that mental health
and life stress conditions increase the risk of fatal and non-fatal
overdoses among adult drug using treatment-seeking cohort users.
Systematic screening of mental health and life stresses (including early
life stress) should be encouraged to provide the necessary assistance for
patients and organize a service that will be trauma-informed. Further
studies should be conducted to assess the different forms of mental
health problems and their association with overdose. Along with the
mental health management, any intervention should promote other
microlevel factors such as healthy lifestyle (i.e., healthy diet and regular
physical activity). Because of the health and economic burden of drug
misuse, acting at the macrolevel is necessary; indeed, that more
attention should be given to substance use through an effective
community-based prevention.
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